Showing results (151-160 of 217) with videos related to
Sort By:
Pageof 22
Breast (Edinburgh, Scotland)|December 28, 2020
Addressing disparities and challenges in underserved patient populations with metastatic breast cancer in EuropeEduard Vrdoljak, Joseph Gligorov, Lieve Wierinck, et al.Stem Cells (Dayton, Ohio)|November 26, 2014
Mesenchymal progenitors expressing TRAIL induce apoptosis in sarcomasGiulia Grisendi, Carlotta Spano, Naomi D'souza, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 6, 2013
Sorafenib does not improve efficacy of chemotherapy in advanced pancreatic cancer: A GISCAD randomized phase II studyStefano Cascinu, Rossana Berardi, Alberto Sobrero, et al.Breast Cancer Research and Treatment|December 15, 2015
5-Fluorouracil, epirubicin and cyclophosphamide versus epirubicin and paclitaxel in node-positive early breast cancer: a phase-III randomized GONO-MIG5 trialLucia Del Mastro, Alessia Levaggi, Andrea Michelotti, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 7, 2012
Pertuzumab monotherapy after trastuzumab-based treatment and subsequent reintroduction of trastuzumab: activity and tolerability in patients with advanced human epidermal growth factor receptor 2-positive breast cancerJavier Cortés, Pierre Fumoleau, Giulia Valeria Bianchi, et al.American Journal of Cancer Research|October 22, 2011
Understanding tumor-stroma interplays for targeted therapies by armed mesenchymal stromal progenitors: the MesenkillersGiulia Grisendi, Rita Bussolari, Elena Veronesi, et al.The Oncologist|June 2, 2019
Impact of 21-Gene Breast Cancer Assay on Treatment Decision for Patients with T1-T3, N0-N1, Estrogen Receptor-Positive/Human Epidermal Growth Receptor 2-Negative Breast Cancer: Final Results of the Prospective Multicenter ROXANE StudyMaria Vittoria Dieci, Valentina Guarneri, Fable Zustovich, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 20, 2021
Neoadjuvant Chemotherapy and Immunotherapy in Luminal B-like Breast Cancer: Results of the Phase II GIADA TrialMaria Vittoria Dieci, Valentina Guarneri, Anna Tosi, et al.ESMO Open|October 6, 2020
Prognostic factors in phyllodes tumours of the breast: retrospective study on 166 consecutive casesElisabetta Di Liso, Michele Bottosso, Marcello Lo Mele, et al.Breast (Edinburgh, Scotland)|March 7, 2013
Gene expression profiling in breast cancer: a clinical perspectiveGrazia Arpino, Daniele Generali, Anna Sapino, et al.Pageof 22